Response to treatment in patients with partial androgen insensitivity due to mutations in the DNA-binding domain of the androgen receptor

Hormone Research

Volumn 53, Issue 2, 2000, Pages 83-88

  Giwercman, Yvonne Lundberg ^a   Nikoshkov, Andrej ^a   Lindsten, Kristina ^a   Byström, Birgitta ^a   Pousette, Ake ^a   Knudtzon, Jørgen ^b   Alm, Jan ^a   Wedell, Anna ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Androgen insensitivity; Androgen receptor; Mutations

Indexed keywords

ANDROGEN RECEPTOR; CHORIONIC GONADOTROPIN; DNA BINDING PROTEIN; TESTOSTERONE;

ANDROGEN INSENSITIVITY SYNDROME; ARTICLE; CASE REPORT; CELL STRAIN COS1; CLINICAL FEATURE; DISEASE COURSE; FEMALE; GENE MUTATION; GENETIC ANALYSIS; HORMONE BINDING; HUMAN; MALE; MISSENSE MUTATION; PRIORITY JOURNAL; REPORTER GENE; TREATMENT OUTCOME;

AMINO ACID SEQUENCE; ANDROGEN-INSENSITIVITY SYNDROME; ANIMALS; BINDING SITES; COS CELLS; DNA; EXONS; HUMANS; MALE; METRIBOLONE; MOLECULAR SEQUENCE DATA; MUTATION; MUTATION, MISSENSE; RECEPTORS, ANDROGEN; TESTOSTERONE; TESTOSTERONE CONGENERS; TRANS-ACTIVATION (GENETICS); TRANSFECTION;

EID: 0033813598     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Lubahn DB, Joseph DR, Sullivan P, Willard HF, French FS, Wilson EM: Cloning of human androgen receptor complementary DNA and localization to the X chromosome. Science 1988;240:327-330.
2. Tsai M-J, O'Malley BW: Molecular mechanism of action of steroid/thyroid receptor superfamily members. Annu Rev Biochem 1991;63:451-486.
3. Lubahn DB, Brown TR, Simental JA, Higgs HN, Migeon CJ, Wilson EM, et al: Sequence of the intron/exon junctions of the coding region of the human androgen receptor gene and identification of a point mutation in a family with complete androgen insensitivity. Proc Natl Acad Sci USA 1989;86:9534-9538.
4. Jenster G, van der Korput H, Trapman J, Brinkmann AO: Identification of two transcription activation units in the N-terminal domain of the human androgen receptor. J Biol Chem 1995;270:7341-7346.
5. Jenster G, Trapman J, Brinkmann AO: Nuclear import of the human androgen receptor. Biochem J 1993;293:761-768.
6. Freedman L: Anatomy of the steroid receptor zinc finger region. Endocr Rev 1992;13:129-145.
7. Zilliacus J, Wright A, Carlstedt-Duke J, Gustafsson J-Å: Structural determinants of DNA-binding specificity by steroid receptors. Mol Endocrinol 1995;9:389-400.
8. Danielsen M, Hinck L, Ringold G: Two amino acids within the knuckle of the first zinc finger specify DNA response element activation by the glucocorticoid receptor. Cell 1989;57: 1131-1138.
9. Umesono K, Evans RM: Determinants of target gene specificity for steroid/thyroid hormone receptors. Cell 1989;57:1139-1146.
10. Quigley C, De Bellis A, Marschke K, El-Awady M, Wilson EM, French FS: Androgen receptor defects: Historical, clinical, and molecular perspectives. Endocr Rev 1995;16:271-321.
11. Chang C, Kokontis J, Liao S: Structural analysis of complementary DNA and amino acid sequences of human and rat androgen receptors. Proc Natl Acad Sci USA 1988;85:7211-7215.
12. Bradford M: Rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
13. Laemmli U: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-685.
14. Luisi B, Xu W, Otwinowski Z, Freedman L, Yamamoto KR, Sigler P: Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA. Nature 1991;352:497-505.
15. Grino PB, Isidoro-Gutierrez R, Griffin JE, Wilson HD: Androgen resistance associated with a qualitative abnormality of the androgen receptor and responsive to high dose androgen therapy. J Clin Endocrinol Metab 1989;68: 578-584.
16. McPhaul MJ, Marcelli M, Tilley WD, Griffin JE, Isidoro-Gutierrez R, Wilson J: Molecular basis of androgen resistance in a family with qualitative abnormality of the androgen receptor and responsive to high-dose androgen therapy. J Clin Invest 1991;87:1413-1421.
17. Kazemi Esfarjani P, Beitel L, Trifiro M, Kaufman M, Rennie P, Sheppard P, et al: Substitution of valine-865 by methionine or leucine in the human androgen receptor causes complete or partial androgen insensitivity, respectively with distinct androgen receptor phenotypes. Mol Endocrinol 1993;7:37-46.
18. Bevan C, Brown BB, Davies HR, Evans BAJ, Hughes IA, Patterson MN: Functional analysis of six androgen receptor mutations identified in patients with partial androgen insensitivity syndrome. Hum Mol Genet 1996;5:265-273.
19. Gast A, Neuschmid-Kaspar F, Klocker H, Cato ACB: A single amino acid exchange abolishes dimerization of the androgen receptor and causes Reifenstein syndrome. Mol Cell Endocrinol 1995;111:93-98.
20. Kaspar F, Klocker H, Denninger A, Cato A: A mutant androgen receptor from patients with Reifenstein syndrome: Identification of the function of a conserved alanine residue in the D box of steroid receptors. Mol Cell Biol 1993; 13:7850-7858.
21. Perlmann T, Umesono K, Rangarajan P, Forman BM, Evans R: Two distinct dimerization interfases differentially modualte target gene specificity of nuclear hormone receptors. Mol Endocrinol 1996;10:958-966.
22. 2-terminal and steroid-binding domains. J Biol Chem 1993;268:19004-19012.
23. Klocker H, Kaspar F, Eberle J, Überreiter S, Radmayr C, Bartshe G: Point mutation in the DNA binding domain of the androgen receptor in two families with Reifenstein syndrome. Am J Hum Genet 1992;50:1318-1327.